细胞表面标誌物市场规模、份额和成长分析（按产品、来源、应用、地区）：产业预测（2024-2031）

2022年，细胞表面标誌物的全球市场规模为279亿美元，从2023年的301.3亿美元成长到2031年的557.7亿美元，预计在预测期内（2024-2031年）将以复合年增长率增长。

由于其在医学研究、诊断和药物开发中的重要作用，全球细胞表面标誌物市场正在强劲成长。这些蛋白质通常被称为细胞表面抗原或 CD 标记，对于识别和分离不同的细胞群以及提高我们对细胞功能和疾病机制的理解至关重要。主要市场驱动因素包括慢性病盛行率的上升、个人化医疗的不断推动以及流式细胞技术和细胞分析技术的进步。在肿瘤学、免疫学和感染疾病的广泛应用也进一步推动了市场动能。然而，设备成本高和分析复杂等挑战限制了潜在的成长。儘管如此，多重和高通量平台的技术创新为市场发展提供了一个有希望的机会。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步

全球细胞表面标誌物市场规模和复合年增长率：按产品分类（2024-2031）

• 市场概况
• 抗体
• PCR阵列

全球细胞表面标誌物市场规模/复合年增长率：依来源分类（2024-2031）

• 市场概况
• 人类
• 老鼠
• 鼠
• 其他的

全球细胞表面标誌物市场规模和复合年增长率：按应用分类（2024-2031）

• 市场概况
• 调查
• 临床

全球细胞表面标誌物市场规模和复合年增长率：按最终用户划分（2024-2031）

• 市场概况
• 研究所
• 製药和生物技术产业

全球细胞表面标誌物市场规模/复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2023年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Abbott Laboratories
• Beckman Coulter Inc.（Danaher Corporation）
• Becton, Dickinson and Company（BD）
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd
• Grifols SA
• Immucor Inc.
• Nihon Kohden Corporation
• Thermo Fisher Scientific Inc.
• Siemens Healthineers
• Sysmex Corporation
• QIAGEN NV
• Agilent Technologies Inc.
• Luminex Corporation（DiaSorin SpA）
• Miltenyi Biotec
• Novus Biologicals
• Cell Signaling Technology（CST）
• Stemcell Technologies
• Fluidigm Corporation（Standard BioTools）

结论和建议

Global Cell Surface Markers Market size was valued at USD 27.9 billion in 2022 and is poised to grow from USD 30.13 billion in 2023 to USD 55.77 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2024-2031).

The global cell surface markers market is witnessing robust growth, driven by their essential role in medical research, diagnostic practices, and drug development. These proteins, commonly referred to as cell surface antigens or CD markers, are critical for identifying and isolating various cell populations, enhancing the understanding of cellular functions and disease mechanisms. Key market drivers include the rising incidence of chronic diseases, an increasing push for personalized medicine, and advancements in flow cytometry and cell analysis technologies. Expanding applications in oncology, immunology, and infectious diseases further contribute to market momentum. However, challenges like high instrument costs and complex analysis limit potential growth. Yet, innovations in multiplexed and high-throughput platforms present promising opportunities for the market's evolution.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Surface Markers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Surface Markers Market Segmental Analysis

Global Cell Surface Markers Market is segmented by product, source, application, end user and region. Based on product, the market is segmented into antibody and PCR array. Based on source, the market is segmented into human, mouse, rat and others. Based on application, the market is segmented into research and clinical. Based on end user, the market is segmented into research institutes and pharmaceutical & biotechnology industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Surface Markers Market

A significant factor propelling the global cell surface markers market is the rising prevalence of chronic diseases. As conditions such as cancer, cardiovascular diseases, and autoimmune disorders become more common, there is a growing need for effective diagnostic and therapeutic tools. Cell surface markers are essential in diagnosing, prognosticating, and enabling targeted treatments, thus playing a pivotal role in personalized medicine. The increasing burden of these persistent health issues across the globe intensifies the demand for advanced cell analysis methodologies, consequently driving growth in the market for cell surface markers. This trend underscores the critical importance of these markers in modern healthcare.

Restraints in the Global Cell Surface Markers Market

One of the primary obstacles faced by the global cell surface markers market is the substantial expense associated with advanced cell analysis instruments and methodologies. The acquisition and ongoing maintenance of complex flow cytometers, hematology analyzers, and other sophisticated analytical platforms can incur significant financial investment. Furthermore, the costs linked to reagents and kits essential for cell surface marker analysis can also be quite high. This financial burden not only restricts the accessibility and adoption of advanced cell analysis technologies, particularly in resource-limited settings and emerging economies but also hinders overall market growth, especially in regions with budget-sensitive healthcare systems.

Market Trends of the Global Cell Surface Markers Market

The global cell surface markers market is experiencing a significant trend towards personalized medicine, significantly influencing its growth dynamics. As healthcare transitions to more tailored therapeutic approaches, the focus on identifying and analyzing cell surface markers has intensified. These markers are critical for discerning specific cell populations, which in turn informs the efficacy of targeted therapies. With advancements in technology facilitating sophisticated cell analysis and detection methods, there is a burgeoning demand for tailored treatments based on an individual's unique cell surface marker profile. This shift towards customization not only enhances treatment outcomes but also propels innovation across the cell surface markers market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Cell Surface Markers Market Size by Product & CAGR (2024-2031)

• Market Overview
• Antibody
• PCR Array

Global Cell Surface Markers Market Size by Source & CAGR (2024-2031)

• Market Overview
• Human
• Mouse
• Rat
• Others

Global Cell Surface Markers Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research
• Clinical

Global Cell Surface Markers Market Size by End User & CAGR (2024-2031)

• Market Overview
• Research Institutes
• Pharmaceutical & Biotechnology Industry

Global Cell Surface Markers Market Size & CAGR (2024-2031)

• North America (Product, Source, Application, End User)
  • USA
  • Canada
• Europe (Product, Source, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Source, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Source, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Source, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (Danaher Corporation)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (DiaSorin SpA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus Biologicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology (CST)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (Standard BioTools)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations